Author
Number of items: 9.
2017
Percutaneous coronary intervention with drug-eluting stent versus coronary artery bypass grafting : A meta-analysis of patients with left main coronary artery disease. (2017)
Nikolaos Spinthakis,
Mohamed Farag,
Diana A Gorog,
Abhiram Prasad,
Hamid Mahmood,
Ying Gue,
David Wellsted,
Ashraf Nabhan
and
Manivannan Srinivasan
![]()
Catheter ablation for AF improves global thrombotic profile and enhances fibrinolysis. (2017)
Maria Niespialowska-Steuden,
Vias Markides,
Mohamed Farag,
David Jones,
Wajid Hussain,
Tom Wong
and
Diana A Gorog
![]()
Allopurinol as a therapeutic option in cardiovascular disease. (2017)
Osita N Okafor,
K Farrington
and
Diana A Gorog
Impaired thrombolytic status predicts adverse cardiac events in patients undergoing primary percutaneous coronary intervention. (2017)
Christos Christopoulos,
Mohamed Farag,
Keith Sullivan,
David Wellsted
and
Diana A Gorog
![]()
2014
PAR-1 antagonist vorapaxar favorably improves global thrombotic status in patients with coronary disease. (2014)
G. Rosser,
P. Tricoci,
D. Morrow,
C. Christopoulos,
M. Niespialowska-Steuden,
Robert Kozarski,
R. Wilcox
and
Diana Gorog
Global Thrombosis Test (GTT) can detect major determinants of haemostasis including platelet reactivity, endogenous fibrinolytic and thrombin generating potential. (2014)
Diana Gorog,
J. Yamamoto,
N. Inoue,
K. Otsui
and
H. Ishii